Connect Marketing to
Health Outcomes

Measure and optimize HCP and DTC marketing based
on the metrics that matter most—patient behavior.

How well is your advertising really working? Understand the impact of marketing on health behavior.
See how it works

Measure and Optimize Your Marketing Investments

Veeva Crossix DIFA is the leading SaaS platform for measuring and optimizing healthcare marketing.
The Crossix Data Platform enables DIFA to tie advertising campaigns to health behavior and prescription sales.



Understand the impact of your DTC digital marketing investments and brand website visits on patient behavior.

Learn more


Understand the audience quality of visitors to HCP websites and the impact of digital campaigns on prescribing behavior.

Learn more



Plan, measure, and optimize DTC linear TV campaigns.

Learn more


Connect cross-channel marketing campaigns to doctor visitation, new patient starts, and adherence.

Learn more

Crossix Technology was Purpose-built to Protect Privacy

Discover how a distributed analytics approach exceeds HIPAA requirements while delivering actionable insights for health brands.

Discover now

DIFA Data Stream

Gain full access to all your underlying DIFA marketing data in a direct feed for in-house analytics.

Learn more

Veeva CRM Boost for DIFA

Understand how personal and non-personal promotion work together to improve patient outcomes.

Learn more

DIFA Partner Program

The DIFA Partner Program was developed to enhance and complement the increasingly complex media ecosystem with direct integrations from leading publishers and platforms.

Learn more

Resources for Measurement and Optimization

Press Release Veeva Announces DIFA Data Stream to Provide Customers with Open Access to Granular DIFA data
Industry Brief The 2020 NAI Code of Conduct for Measurement of Digital Health Campaigns
Press Release Crossix Launches DIFA Partner Program to Enable Direct Integrations with Leading Publishers and Media Platforms
Blog Ashley Slavik, Chief Privacy Officer & Lead Data Counsel, discusses how pharma marketers can ensure their measurement approach is NAI-compliant.